Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder — Stella

Home/Nicotine Addiction/

View on ClinicalTrials.gov

Recruiting

Back to Nicotine Addiction trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

University California, San Diego, San Diego, California

Key details

Phase

Very early testing

Sponsor

University of California, San Diego

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~200 participants

Started

November 2024

Primary completion

August 2028

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

22 Years and older

Last updated March 2026